NEWS, EVENTS, and DEADLINES

February 25, 2025

NJ ACTS Pilot Program 2025

NJ ACTS Helix
View RFA
Webinar Registration
LOI Form

The 2025 pilot program is designed to propel clinical and translational science initiatives throughout NJ ACTS, engaging our academic alliance partners (Rutgers, Princeton, and New Jersey Institute of Technology) and our health system partner, RWJ Barnabas Health.


Our initiative seeks to furnish initial resources aimed at nurturing programs that can then vie competitively for expanded extramural support, leveraging funding opportunities such as Element E or RC2 (see RFA for explanation) studies pertinent to NJ ACTS or through independent extramural avenues (R or K series grants).


Total funding support may not exceed $40,000 for 6-9 months.

Key Pilot Program Dates


  • Release Date: February 25, 2025
  • Pre-submission Webinar: March 7, 2025 at 1:00 - 2:00 PM

Register at: https://rutgers.zoom.us/meeting/register/-8N9UBuvQROX7rxEuw1bqg

  • Letter of Intent Deadline: March 14, 2025(required)(by 5:00 EST).

Link to LOI form: https://redcap.rutgers.edu/surveys/?s=JWT39TWX3L8JXY48

  • Application Deadline: April 11, 2025 (required by 5:00 pm EST).
  • Award Notification: Summer 2025
  • Earliest Start Date: Dependent on regulatory approvals and NIH/NCATS approval.

Become an NJ ACTS K12 Scholar

NJ ACTS K12 - DEVELOP Scholar Program


NJ ACTS is delighted to announce the next cycle of its Clinical-Translational Scientist Junior Faculty Award Program (K12). This NIH/NCATS-funded Institutional Career Development Award, known as DEVELOP, is designed to support junior faculty pursuing careers in clinical-translational science. DEVELOP Scholars receive mentored research training, professional development opportunities, and membership to the Rutgers Health Society of Scholars.

KEY DATES


• Letter of Intent Due: March 14

• Full Application Due: April 23

• Interviews: May 2025

• Notification of Awards: June 4

• Award Start Date: July 1


View Flyer for Details
Initiate the Full RFA

Questions? Contact Tracey Sharp

Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events

NJ ACTS GREAT Core

Guest Seminar


Disentangling the genetics of comorbid substance use and depression

Emily Hartwell, PhD

Philadelphia VA Medical Center

University of Pennsylvania

If you would like to schedule a 1-1 meeting during Dr. Hartwell's campus visit, please contact host Dr. Jessica Salvatore at jessica.salvatore@rutgers.edu.



This event is co-sponsored by the Genes, Neurodevelopment, and Addictions Program in the Center for Psychiatric Health and Genomics and the NJACTS Genetically informed Research, Education, and Treatment Core. 

February 28

11 am -12 pm


Hybrid Event


University Behavioral Health Care, North D203

Piscataway

or

On Zoom


NJ ACTS Special Populations Core

2025 Seminar Series


Medication treatment for opioid use disorder: Leveraging claims and trial data to advance optimal and equitable outcomes


with

Rachael K. Ross, PhD 

Columbia University


Dr. Ross will discuss two recent research projects, one assessing the real-world comparative effectiveness of two medications in a Medicaid sample and one examining racial and ethnic disparities in medication dosing within randomized clinical trials.

March 4

1 - 2 PM


on Zoom

Register
Flyer
NJ ACTS Helix


Clinical Trials Office

Special Seminar


Principal Investigator Roles and Responsibilities:

A Review of FDA 483's and BIMO Inspection Findings

Gain valuable insights into common compliance pitfalls and best practices to ensure regulatory success. Enhance your understanding and stay inspection-ready!

View Flyer

March 10, 2025



12 - 1 pm


Virtual

Register
 

Information Sessions

Propelus I-Corps


Learn how I-Corps can help you make a real-world impact with your innovations by turning them into products/services that create value in the market.


March 12

12 - 1 pm

Register

National I-Corps


Join a webinar led by a Hub instructor to learn how to apply to the National I-Corps Teams program, which provides a $50,000 grant from NSF.


March 25

12 - 1 pm

Register
 

NJ ACTS Virtual Seminar on YouTube

NJ ACTS Team Science Across the Consortium

Virtual Seminar Series


Brain Health Institute (BHI) Center Pilot Project


Collaboration is essential for advancing research goals, particularly in complex fields like addiction, where diverse expertise fosters innovative solutions. In addition, precision medicine, which tailors treatment approaches based on genetic and environmental factors, can significantly improve outcomes. This seminar highlights how a team coalesces around a new idea and builds it out over time in preparation for a major NIH submission.


presented by

Danielle Dick, PhD, Rutgers Robert Wood Johnson Medical School

Tammy Chung, PhD, Center for Population Health, Rutgers

Video link for Team Science Seminar from 2/2025

NJ ACTS in the News

Showcasing the

NJ ACTS Clinical and Translational Pilot Grant Awardees


NJ ACTS awarded pilot grants to four outstanding projects under its Clinical and Translational Science Pilot Program. This is the second pilot to be highlighted.


NJIT Researchers Studying Ultrasound Responsive Therapeutic Gas Microbubbles for Localized Treatment of Cardiac Injury

NJIT Bio-Medical Engineering researchers Eunjung Lee, PhD, and Rajarshi Chattaraj, PhD, were awarded a New Jersey Alliance for Clinical and Translational Science (NJ ACTS) pilot grant to address the pressing need to develop safe therapeutics to treat cardiovascular disease, the leading cause of disability and mortality in the western world. They are investigating the use of microbubbles with the goal of producing a side-effect-free treatment for localized delivery of therapeutic gases to the heart.

Victoria Abraira Named a Sloan Fellow


Dr. Abraira, who researches the sense of touch and its role in movement, socialization, and pain perception, has been awarded a 2025 Sloan Research Fellowship, among the most prestigious in science for early-career investigators. Read the Full Article


Dr. Abraira is an Assistant Professor in Rutgers Department of Cell Biology and Neuroscience and a 2021 NJ ACTS Pilot Award recipient.

Rutgers Health Researchers Analyzed Medical Trends for the Most Common Childhood Rheumatic Disorder


The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to Rutgers Health researchers. Their study, published in Arthritis & Rheumatology, examined more than 20 years of data from nearly 14,000 children with JIA throughout the nation. Read the Full Article


Daniel Horton, MD, MSCE, Associate Professor of Pediatric and Epidemiology at Rutgers Center for Pharmacoepidemiology and Treatment Science, is a senior author of the study and a Co-Lead of NJ ACTS Team Science.


RFA Opportunity for Summer Internship

The Rutgers Health Center for Biomedical Informatics

& Health Artificial Intelligence (BMIHAI)


Rutgers Health Roadmap Initiative

2025 Request for Applications

Summer Internship Program in Biomedical Informatics and Health AI

This RFA solicits project applications for the Summer Internship initiative, designed to provide a platform for undergraduate and MS Rutgers students to participate in hands-on projects focused on Biomedical Data Science and Health AI and introduce students to careers in Computational Biomedicine and AI in Healthcare. 

Flyer
RFA


Information Webinar

March 3

5 - 6 pm

Register

Faculty Proposal Deadline

March 10

Submit
 

Summer Research Opportunity

An NIH-funded R25 Summer

Research-Education Program

For students from the following schools interested in careers as clinician-scientists:

  • New Jersey Medical School
  • Robert Wood Johnson Medical School
  • School of Dental Medicine
  • School of Health Professions


A Research-Education Program with opportunities for:

  • Participation in cardiology, pulmonology, and hematology/immunology research projects
  • Career-enhancing guidance and advice from faculty experts and clinician scientists
  • Improving your oral communication skills
  • $4,800 stipend and assistance with housing expenses




Deadline

March 2nd

Apply
Flyer

Funding Opportunities

 

Funding for Inventions


The Rutgers Office for Research provides funding and mentoring to support inventors in the process of commercializing their inventions.


There are two major funding opportunities available to Rutgers inventors:  

TechAdvance®


TechAdvance (Early-Stage Technology Fund); TechXpress (Fast-Track Program) - up to $100,000 (TechAdvance) and up to $25,000 (TechXpress)

HealthAdvance®


HealthAdvance (Early-Stage Life Science Technologies) - up to $150,000 (HealthAdvance) and up to $50,000 (HealthXpress)

 

CTSA News and Events

NCATS, NIH, and Federal News and Events

Registration is now open for the FDA-NIH Rare Disease Day — a two-day event co-hosted by NCATS and the U.S. Food and Drug Administration!



February 27-28


Free

In-person or Virtual




Learn More and Register

Collaboration Webinars from the

Trial Innovation Network


Hear from CTSA TIN experts on trial-related topics to improve your project

REDCap Randomization 2.0: A New Tool to Support Platform, Adaptive, & Decentralized Trials


March 3, 2025

12 - 1 pm


Register


Demystifying 21 CFR Part 11 Compliance for REDCap


March 19, 2025

12 - 1 pm


Register

Read More
 
NJ ACTS Publications

NJ ACTS Publication Highlights


IFI16 phase separation via multi-phosphorylation drives innate immune signaling. Liu D, Lum KK, Treen N, Nύñez CT, Yang J, Howard TR, Levine M, Cristea IM. Nucleic Acids Research (2023). doi: 10.1093/nar/gkad449 PMID: 37283074.


Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries. Hillary Samples, Molly A. Nowels, Arthur R. Williams, Mark Olfson, Stephen Crystal. American Journal of Preventive Medicine. VOLUME 65, ISSUE 1, P19-29, JULY 2023.  March 10, 2023 DOI:https://doi.org/10.1016/j.amepre.2023.01.037

Click Here for More NJ ACTS Publications
 
 

In Case You Missed It

Robert Wood Johnson Foundation’s Health Policy Research Scholars Program for Full-Time 2nd Year Doctoral Students. Learn more and apply by March 11.

Digital Archive of Protein Structures - Federal funds totaling $49.4 million will underwrite efforts at the Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank through 2028. Read the Full Article

Spring Mentor Workshops 2025 - Learn how you can offer guidance and advice based on your own experiences. View Flyer.

NCATS Translational Science Education and Training Challenge - Phase 1 is open until 04/30/25. Challenge types: Scientific; Education and Training, Total cash prizes: $50,000. Read More.

Employment Opportunity - Grants Manager. Princeton University seeks a highly motivated, highly experienced individual to serve as Grants Manager (GM) in the Department of Molecular Biology. This position is fully remote. Job Description and Apply Here

Apply for the Translational Science Interagency Fellowship Program -NCATS jointly sponsors the Translational Science Interagency Fellowship (TSIF) with the U.S. Food and Drug Administration to train fellows in translational science and regulatory science. Learn More about the Program

 
View NJ ACTS Services
Sign Up to Receive the NJ ACTS Newsletter
Click Here for NJ ACTS Newsletter Archive
 

NJ ACTS is a partnership between Rutgers, NJIT, Princeton, and RWJ Barnabas Health. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.

Components

Element B

Administration

Element C1

Workforce Development

Element C2

Community & Stakeholder Engagement

Element D1

*Biostatistics, Epidemiology &

Research Design (BERD)

*Team Science

*Regulatory Knowledge & Support

*Special Populations in Research

*Biomarkers

*Genetically informed Research

Education & Training (GREAT)

*Clinical Trials Office

Element D2

Clinical & Translational Science Pilots

Element D3

Clinical Informatics

Element E1

Clinical & Translational Science Research: Novel Genetic Services Model

Element E2

Clinical & Translational Science Research: Translating Evidence on Opioid Overdose


Additional Components

*Mentored Career Development DEVELOP (K12)

*Predoctoral Training ASCENT (T32)

*Short-Term Research CREST (R25)



Working Groups

*Health Policy in Action

*Dissemination & Implementation Science

*Team Science

*Learning Health System

*Engagement for Impact

Visit NJ ACTS
View NJ ACTS Calendar

CTSA Hub Funding Opportunities

Become a members of NJ ACTS

How to cite the CTSA Grant

 
Connect with us
Facebook  Twitter  Youtube  LinkedIn

This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.

 

New Jersey Alliance for Clinical and Translational Science

89 French St., Suite 4211

New Brunswick, NJ

 

Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved

Send story ideas to NJACTS@rbhs.rutgers.edu

 

UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788(starting 7/1/2024), T32TR004782 (starting 9/1/2024), R25TR004777 (starting 9/1/2024)

 
Visit our Website